2.7M XNAS Volume
XNAS 19 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Christopher J. Joyce | Chief Legal and Admin. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 70,789 | 457,763 | - | 0 | Common Stock | |
| David C. Hodgson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 18,710 | 154,426 | - | 0 | Common Stock | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 12,258 | 290,867 | - | 0 | Common Stock | |
| Jody L. Bilney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 15,484 | 113,228 | - | 0 | Common Stock | |
| John E. Kao | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 338,710 | 5,019,252 | - | 0 | Common Stock | |
| Joseph Konowiecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 12,258 | 1,147,146 | - | 0 | Common Stock | |
| Yon Yoon Jorden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 12,258 | 92,734 | - | 0 | Common Stock | |
| Margaret M. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 12,258 | 128,878 | - | 0 | Common Stock | |
| Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 12,258 | 357,435 | - | 0 | Common Stock | |
| Robbert Vorhoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 18,710 | 154,426 | - | 0 | Common Stock | |
| Dawn Maroney | President | Sale of securities on an exchange or to another person at price $ 15.99 per share. | 13 Mar 2025 | 30,000 | 2,417,700 | - | 16.0 | 479,688 | Common Stock |
| Dawn Maroney | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 170,968 | 2,447,700 | - | 0 | Common Stock | |
| Robert Thomas Freeman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 93,548 | 1,496,410 | - | 0 | Common Stock | |
| Hakan Kardes | Chief Experience Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 39,677 | 717,814 | - | 0 | Common Stock | |
| Robert L. Scavo | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 48,868 | 716,974 | - | 0 | Common Stock | |
| Hyong Kim | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 58,065 | 544,367 | - | 0 | Common Stock | |
| Sebastian Burzacchi | COO - Mgmt Services Org | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 39,677 | 257,072 | - | 0 | Common Stock | |
| Andreas P. Wagner | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 35,109 | 235,994 | - | 0 | Common Stock | |
| Dawn Maroney | President | Sale of securities on an exchange or to another person at price $ 15.42 per share. | 12 Mar 2025 | 26,858 | 2,277,117 | - | 15.4 | 414,234 | Common Stock |
| Dawn Maroney | President | Sale of securities on an exchange or to another person at price $ 15.74 per share. | 12 Mar 2025 | 385 | 2,276,732 | - | 15.7 | 6,059 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.74 per share. | 12 Mar 2025 | 208 | 1,402,862 | - | 15.7 | 3,273 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.42 per share. | 12 Mar 2025 | 14,484 | 1,403,070 | - | 15.4 | 223,388 | Common Stock |
| Hakan Kardes | Chief Experience Officer | Sale of securities on an exchange or to another person at price $ 15.74 per share. | 12 Mar 2025 | 69 | 678,137 | - | 15.7 | 1,086 | Common Stock |
| Hakan Kardes | Chief Experience Officer | Sale of securities on an exchange or to another person at price $ 15.42 per share. | 12 Mar 2025 | 4,787 | 678,206 | - | 15.4 | 73,830 | Common Stock |
| Robert L. Scavo | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 15.42 per share. | 12 Mar 2025 | 5,238 | 668,181 | - | 15.4 | 80,786 | Common Stock |
| Robert L. Scavo | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 15.73 per share. | 12 Mar 2025 | 75 | 668,106 | - | 15.7 | 1,180 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.36 per share. | 11 Mar 2025 | 89,900 | 2,093,200 | - | 15.4 | 1,380,657 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.42 per share. | 11 Mar 2025 | 52,372 | 4,681,292 | - | 15.4 | 807,739 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.74 per share. | 11 Mar 2025 | 750 | 4,680,542 | - | 15.7 | 11,803 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.72 per share. | 11 Mar 2025 | 100 | 2,093,100 | - | 15.7 | 1,572 | Common Stock |
| Hyong Kim | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.05 per share. | 07 Mar 2025 | 21,006 | 486,870 | - | 15.0 | 316,037 | Common Stock |
| Hyong Kim | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.65 per share. | 07 Mar 2025 | 568 | 486,302 | - | 15.7 | 8,890 | Common Stock |
| Christopher J. Joyce | Chief Legal and Admin. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 58,400 | 422,845 | - | 0 | Common Stock | |
| Christopher J. Joyce | Chief Legal and Admin. Officer | Sale of securities on an exchange or to another person at price $ 15.53 per share. | 04 Mar 2025 | 10,871 | 386,974 | - | 15.5 | 168,827 | Common Stock |
| Christopher J. Joyce | Chief Legal and Admin. Officer | Sale of securities on an exchange or to another person at price $ 15.58 per share. | 04 Mar 2025 | 25,000 | 397,845 | - | 15.6 | 389,615 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.53 per share. | 04 Mar 2025 | 554,713 | 4,733,664 | - | 15.5 | 8,614,693 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 2,543,124 | 5,288,377 | - | 0 | Common Stock | |
| Dawn Maroney | President | Sale of securities on an exchange or to another person at price $ 15.53 per share. | 04 Mar 2025 | 278,917 | 2,303,975 | - | 15.5 | 4,331,581 | Common Stock |
| Dawn Maroney | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 1,020,442 | 2,582,892 | - | 0 | Common Stock | |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.53 per share. | 04 Mar 2025 | 218,295 | 1,417,554 | - | 15.5 | 3,390,121 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.58 per share. | 04 Mar 2025 | 250,000 | 1,635,849 | - | 15.6 | 3,895,775 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 1,020,442 | 1,885,849 | - | 0 | Common Stock | |
| Hakan Kardes | Chief Experience Officer | Sale of securities on an exchange or to another person at price $ 15.53 per share. | 04 Mar 2025 | 86,659 | 682,993 | - | 15.5 | 1,345,814 | Common Stock |
| Hakan Kardes | Chief Experience Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 474,208 | 769,652 | - | 0 | Common Stock | |
| Robert L. Scavo | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 15.53 per share. | 04 Mar 2025 | 55,403 | 673,419 | - | 15.5 | 860,409 | Common Stock |
| Robert L. Scavo | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 292,000 | 728,822 | - | 0 | Common Stock | |
| Hyong Kim | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 58,400 | 528,896 | - | 0 | Common Stock | |
| Hyong Kim | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.53 per share. | 04 Mar 2025 | 7,626 | 507,876 | - | 15.5 | 118,432 | Common Stock |
| Hyong Kim | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.72 per share. | 04 Mar 2025 | 13,394 | 515,502 | - | 15.7 | 210,539 | Common Stock |
| Dawn Maroney | President | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Mar 2025 | 13,647 | 1,562,450 | - | 0 | Common Stock | |
| Dawn Maroney | President | Sale of securities on an exchange or to another person at price $ 13.72 per share. | 18 Feb 2025 | 30,000 | 1,576,097 | - | 13.7 | 411,471 | Common Stock |
| Andreas P. Wagner | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 14.38 per share. | 12 Feb 2025 | 14,878 | 200,885 | - | 14.4 | 213,946 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.23 per share. | 11 Feb 2025 | 90,000 | 2,183,100 | - | 14.2 | 1,280,304 | Common Stock |
| Hakan Kardes | Chief Experience Officer | Sale of securities on an exchange or to another person at price $ 14.98 per share. | 24 Jan 2025 | 14,500 | 295,444 | - | 15.0 | 217,277 | Common Stock |
| Hakan Kardes | Chief Experience Officer | Sale of securities on an exchange or to another person at price $ 14.99 per share. | 21 Jan 2025 | 10,500 | 309,944 | - | 15.0 | 157,370 | Common Stock |
| Dawn Maroney | President | Sale of securities on an exchange or to another person at price $ 13.61 per share. | 15 Jan 2025 | 30,000 | 1,606,097 | - | 13.6 | 408,384 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.81 per share. | 13 Jan 2025 | 52,386 | 2,310,714 | - | 12.8 | 671,023 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.41 per share. | 13 Jan 2025 | 37,614 | 2,273,100 | - | 13.4 | 504,471 | Common Stock |
| Maroney Dawn | President, Markets | Sale of securities on an exchange or to another person at price $ 11.33 per share. | 16 Dec 2024 | 30,000 | 1,636,097 | - | 11.3 | 340,008 | Common Stock |
| E. Kao John | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.65 per share. | 11 Dec 2024 | 90,000 | 2,363,100 | - | 11.7 | 1,048,689 | Common Stock |
| Sebastian Burzacchi | COO - Mgmt Services Org | Sale of securities on an exchange or to another person at price $ 11.26 per share. | 10 Dec 2024 | 8,550 | 217,395 | - | 11.3 | 96,273 | Common Stock |
| Hyong Kim | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.20 per share. | 05 Dec 2024 | 62,574 | 470,496 | - | 12.2 | 763,572 | Common Stock |
| Kardes Hakan | Chief Experience Officer | Sale of securities on an exchange or to another person at price $ 12.80 per share. | 27 Nov 2024 | 35,000 | 320,444 | - | 12.8 | 448,140 | Common Stock |
| Dawn Maroney | President, Markets | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Nov 2024 | 30,000 | 1,666,097 | - | 0 | Common Stock | |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 11.35 per share. | 15 Nov 2024 | 30,000 | 1,696,097 | - | 11.4 | 340,560 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.42 per share. | 11 Nov 2024 | 90,000 | 2,453,100 | - | 13.4 | 1,207,944 | Common Stock |
| Joseph Konowiecki | Director | Sale of securities on an exchange or to another person at price $ 13.73 per share. | 11 Nov 2024 | 6,920 | 1,134,888 | - | 13.7 | 95,012 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.42 per share. | 11 Nov 2024 | 30,500 | 92,929 | - | 13.4 | 409,356 | Common Stock |
| Hakan Kardes | Chief Experience Officer | Sale of securities on an exchange or to another person at price $ 13.06 per share. | 01 Nov 2024 | 20,500 | 355,444 | - | 13.1 | 267,699 | Common Stock |
| Hakan Kardes | Chief Experience Officer | Sale of securities on an exchange or to another person at price $ 12.98 per share. | 01 Nov 2024 | 4,500 | 375,944 | - | 13.0 | 58,413 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.04 per share. | 29 Oct 2024 | 36,197 | 123,429 | - | 12.0 | 435,982 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 29 Oct 2024 | 4,483 | 159,626 | - | 12.0 | 53,856 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 10.77 per share. | 15 Oct 2024 | 30,000 | 1,726,097 | - | 10.8 | 323,082 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.50 per share. | 14 Oct 2024 | 30,500 | 164,109 | - | 11.5 | 350,872 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.33 per share. | 09 Oct 2024 | 90,000 | 2,543,100 | - | 11.3 | 1,019,538 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.04 per share. | 08 Oct 2024 | 39,320 | 194,609 | - | 12.0 | 473,350 | Common Stock |
| Hyong Kim | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.03 per share. | 08 Oct 2024 | 22,460 | 533,070 | - | 11.0 | 247,734 | Common Stock |
| Christopher J. Joyce | Chief Legal and Admin. Officer | Sale of securities on an exchange or to another person at price $ 11.79 per share. | 01 Oct 2024 | 667 | 364,445 | - | 11.8 | 7,866 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.01 per share. | 01 Oct 2024 | 9,125 | 233,929 | - | 11.0 | 100,432 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.38 per share. | 01 Oct 2024 | 9,175 | 243,054 | - | 11.4 | 104,424 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.11 per share. | 01 Oct 2024 | 12,200 | 252,229 | - | 10.1 | 123,399 | Common Stock |
| Joseph Konowiecki | Director | Sale of securities on an exchange or to another person at price $ 11.77 per share. | 17 Sep 2024 | 16,413 | 1,141,808 | - | 11.8 | 193,181 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.70 per share. | 16 Sep 2024 | 90,000 | 2,633,100 | - | 11.7 | 1,052,874 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 11.70 per share. | 16 Sep 2024 | 30,000 | 1,756,097 | - | 11.7 | 351,027 | Common Stock |
| Joseph Konowiecki | Director | Sale of securities on an exchange or to another person at price $ 11.00 per share. | 12 Sep 2024 | 25,000 | 1,183,221 | - | 11.0 | 275,093 | Common Stock |
| Joseph Konowiecki | Director | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 12 Sep 2024 | 25,000 | 1,158,221 | - | 12.0 | 300,013 | Common Stock |
| Hakan Kardes | Chief Experience Officer | Sale of securities on an exchange or to another person at price $ 11.48 per share. | 12 Sep 2024 | 25,000 | 380,444 | - | 11.5 | 287,053 | Common Stock |
| Christopher J. Joyce | Chief Legal and Admin. Officer | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 11 Sep 2024 | 10,159 | 365,112 | - | 10.0 | 101,712 | Common Stock |
| Christopher J. Joyce | Chief Legal and Admin. Officer | Sale of securities on an exchange or to another person at price $ 9.45 per share. | 11 Sep 2024 | 24,467 | 375,271 | - | 9.4 | 231,213 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.00 per share. | 11 Sep 2024 | 120,500 | 278,929 | - | 11.0 | 1,326,054 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 11 Sep 2024 | 14,500 | 264,429 | - | 12.0 | 174,013 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 11 Sep 2024 | 8,561 | 399,429 | - | 10.0 | 85,688 | Common Stock |
| Christopher J. Joyce | Chief Legal and Admin. Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 04 Sep 2024 | 4,541 | 399,738 | - | 10.0 | 45,422 | Common Stock |
| Christopher J. Joyce | Chief Legal and Admin. Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 04 Sep 2024 | 1,300 | 404,279 | - | 10 | 13,000 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 04 Sep 2024 | 10 | 412,779 | - | 10 | 100 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 04 Sep 2024 | 4,789 | 407,990 | - | 10.0 | 47,913 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 04 Sep 2024 | 1,640 | 412,789 | - | 10 | 16,400 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 9.02 per share. | 22 Aug 2024 | 7,074 | 1,789,023 | - | 9.0 | 63,780 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 9.06 per share. | 22 Aug 2024 | 2,926 | 1,786,097 | - | 9.1 | 26,510 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 8.70 per share. | 15 Aug 2024 | 20,000 | 1,796,097 | - | 8.7 | 174,020 | Common Stock |
| Jeffrey H. Margolis | Director | Sale of securities on an exchange or to another person at price $ 8.83 per share. | 14 Aug 2024 | 1,200 | 413,533 | - | 8.8 | 10,596 | Common Stock |
| Christopher J. Joyce | Chief Legal and Admin. Officer | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 02 Aug 2024 | 1,233 | 405,679 | - | 9 | 11,097 | Common Stock |
| Christopher J. Joyce | Chief Legal and Admin. Officer | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 02 Aug 2024 | 100 | 405,579 | - | 9.0 | 901 | Common Stock |
| Joseph Konowiecki | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 17 Jul 2024 | 24,900 | 1,208,321 | - | 10 | 249,000 | Common Stock |
| Joseph Konowiecki | Director | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 17 Jul 2024 | 100 | 1,208,221 | - | 10.0 | 1,001 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 17 Jul 2024 | 36,700 | 1,816,097 | - | 10.0 | 367,209 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 17 Jul 2024 | 832 | 1,852,797 | - | 10.0 | 8,328 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 17 Jul 2024 | 39,305 | 1,853,629 | - | 10 | 393,050 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 17 Jul 2024 | 23,163 | 1,892,934 | - | 10.0 | 231,642 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 17 Jul 2024 | 22,100 | 497,329 | - | 10.0 | 221,013 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 17 Jul 2024 | 38,858 | 414,429 | - | 10.0 | 388,790 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 17 Jul 2024 | 44,042 | 453,287 | - | 10.0 | 440,433 | Common Stock |
| Hakan Kardes | Chief Experience Officer | Sale of securities on an exchange or to another person at price $ 9.98 per share. | 16 Jul 2024 | 25,000 | 405,444 | - | 10.0 | 249,500 | Common Stock |
| Jeffrey H. Margolis | Director | Sale of securities on an exchange or to another person at price $ 8.94 per share. | 15 Jul 2024 | 1,200 | 414,733 | - | 8.9 | 10,728 | Common Stock |
| Christopher J. Joyce | Chief Legal and Admin. Officer | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 12 Jul 2024 | 300 | 421,946 | - | 9 | 2,700 | Common Stock |
| Christopher J. Joyce | Chief Legal and Admin. Officer | Sale of securities on an exchange or to another person at price $ 9.05 per share. | 12 Jul 2024 | 15,034 | 406,912 | - | 9.0 | 136,032 | Common Stock |
| Joseph Konowiecki | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 9.06 per share. | 12 Jul 2024 | 22,400 | 1,233,221 | - | 9.1 | 203,036 | Common Stock |
| Joseph Konowiecki | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 12 Jul 2024 | 2,600 | 1,255,621 | - | 9.0 | 23,403 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 12 Jul 2024 | 300 | 1,955,797 | - | 9 | 2,700 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 9.04 per share. | 12 Jul 2024 | 39,700 | 1,916,097 | - | 9.0 | 358,690 | Common Stock |
| Christopher J. Joyce | Chief Legal and Admin. Officer | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 01 Jul 2024 | 666 | 422,246 | - | 8 | 5,328 | Common Stock |
| Christopher J. Joyce | Chief Legal and Admin. Officer | Sale of securities on an exchange or to another person at price $ 8.01 per share. | 14 Jun 2024 | 16,000 | 422,912 | - | 8.0 | 128,198 | Common Stock |
| Jeffrey H. Margolis | Director | Sale of securities on an exchange or to another person at price $ 8.06 per share. | 14 Jun 2024 | 1,200 | 415,933 | - | 8.1 | 9,672 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 8.21 per share. | 12 Jun 2024 | 20,000 | 1,956,097 | - | 8.2 | 164,200 | Common Stock |
| Kim Hyong | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.05 per share. | 19 Mar 2024 | 5,576 | 555,530 | - | 5.1 | 28,163 | Common Stock |
| Kardes Hakan | Chief Experience Officer | Sale of securities on an exchange or to another person at price $ 5.05 per share. | 19 Mar 2024 | 18,964 | 434,807 | - | 5.1 | 95,783 | Common Stock |
| Maroney Dawn | President, Markets | Sale of securities on an exchange or to another person at price $ 4.83 per share. | 19 Mar 2024 | 13,252 | 1,986,248 | - | 4.8 | 64,007 | Common Stock |
| Robert Scavo L. | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 5.05 per share. | 19 Mar 2024 | 3,078 | 438,643 | - | 5.1 | 15,546 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 5.05 per share. | 19 Mar 2024 | 15,861 | 1,999,500 | - | 5.1 | 80,111 | Common Stock |
| Freeman Robert Thomas | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.05 per share. | 19 Mar 2024 | 28,522 | 869,706 | - | 5.1 | 144,059 | Common Stock |
| Christopher J. Joyce | Chief Legal and Admin. Officer | Sale of securities on an exchange or to another person at price $ 5.05 per share. | 19 Mar 2024 | 25,060 | 438,912 | - | 5.1 | 126,573 | Common Stock |
| Christopher J. Joyce | Chief Legal and Admin. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 196,138 | 463,972 | - | 0 | Common Stock | |
| John E. Kao | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.82 per share. | 14 Mar 2024 | 103,000 | 2,745,253 | - | 4.8 | 496,779 | Common Stock |
| David C. Hodgson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 50,000 | 135,716 | - | 0 | Common Stock | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 40,000 | 278,609 | - | 0 | Common Stock | |
| Jeffrey H. Margolis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 30,000 | 104,451 | - | 0 | Common Stock | |
| Jody L. Bilney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 40,000 | 97,744 | - | 0 | Common Stock | |
| John E. Kao | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 330,000 | 2,642,253 | - | 0 | Common Stock | |
| Joseph Konowiecki | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 70,000 | 1,258,221 | - | 0 | Common Stock | |
| Yon Yoon Jorden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 30,000 | 80,476 | - | 0 | Common Stock | |
| Thomas J. Carella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 40,000 | 124,478 | - | 0 | Common Stock | |
| Margaret M. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 33,500 | 116,620 | - | 0 | Common Stock | |
| Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 30,000 | 345,177 | - | 0 | Common Stock | |
| Robbert Vorhoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 50,000 | 135,716 | - | 0 | Common Stock | |
| Dawn Maroney | President, Markets | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 206,890 | 2,036,898 | - | 0 | Common Stock | |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 4.89 per share. | 13 Mar 2024 | 21,537 | 2,015,361 | - | 4.9 | 105,340 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.89 per share. | 13 Mar 2024 | 11,858 | 898,228 | - | 4.9 | 57,999 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 200,710 | 910,086 | - | 0 | Common Stock | |
| Hakan Kardes | Chief Experience Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 140,190 | 458,097 | - | 0 | Common Stock | |
| Hakan Kardes | Chief Experience Officer | Sale of securities on an exchange or to another person at price $ 4.89 per share. | 13 Mar 2024 | 4,326 | 453,771 | - | 4.9 | 21,159 | Common Stock |
| Robert L. Scavo | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 80,000 | 446,573 | - | 0 | Common Stock | |
| Robert L. Scavo | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 4.89 per share. | 13 Mar 2024 | 4,852 | 441,721 | - | 4.9 | 23,732 | Common Stock |
| Hyong Kim | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 158,970 | 561,106 | - | 0 | Common Stock | |
| Sebastian Burzacchi | COO - Mgmt Services Org | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 100,000 | 225,945 | - | 0 | Common Stock | |
| Andreas P. Wagner | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 60,000 | 215,763 | - | 0 | Common Stock | |
| John E. Kao | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.39 per share. | 08 Mar 2024 | 34,520 | 2,312,253 | - | 5.4 | 186,063 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 5.44 per share. | 08 Mar 2024 | 23,000 | 1,830,008 | - | 5.4 | 125,076 | Common Stock |
| Dawn Maroney | President, Markets | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Mar 2024 | 6,000 | 1,853,008 | - | 0 | Common Stock | |
| Andreas P. Wagner | Chief People & Culture Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 155,763 | 155,763 | - | 0 | Common Stock | |
| Sebastian Burzacchi | COO - Mgmt Services Org | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 125,945 | 125,945 | - | 0 | Common Stock | |
| H. Margolis Jeffrey | Director | Sale of securities on an exchange or to another person at price $ 8.46 per share. | 14 Dec 2023 | 1,200 | 417,133 | - | 8.5 | 10,152 | Common Stock |
| Margolis Jeffrey H. | Director | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 06 Dec 2023 | 1,200 | 418,333 | - | 8 | 9,600 | Common Stock |
| Dawn Maroney | President, Markets | Gift of securities by or to the insider at price $ 0.00 per share. | 08 May 2023 | 65,000 | 1,864,308 | - | 0 | Common Stock | |
| Dawn Maroney | President, Markets | Gift of securities by or to the insider at price $ 0.00 per share. | 08 May 2023 | 5,300 | 1,859,008 | - | 0 | Common Stock | |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.11 per share. | 29 Mar 2023 | 34,506 | 2,346,773 | - | 6.1 | 210,946 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 6.11 per share. | 29 Mar 2023 | 7,178 | 1,929,308 | - | 6.1 | 43,881 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.26 per share. | 29 Mar 2023 | 3,290 | 709,376 | - | 6.3 | 20,608 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.11 per share. | 29 Mar 2023 | 5,312 | 712,666 | - | 6.1 | 32,474 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 6.11 per share. | 29 Mar 2023 | 3,286 | 1,088,651 | - | 6.1 | 20,088 | Common Stock |
| Richard A. Cross | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 6.11 per share. | 29 Mar 2023 | 1,710 | 393,460 | - | 6.1 | 10,454 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.33 per share. | 14 Mar 2023 | 39,101 | 2,381,279 | - | 6.3 | 247,392 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 6.33 per share. | 14 Mar 2023 | 20,006 | 1,938,886 | - | 6.3 | 126,578 | Common Stock |
| Dawn Maroney | President, Markets | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Mar 2023 | 2,400 | 1,936,486 | - | 0 | Common Stock | |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.33 per share. | 14 Mar 2023 | 13,470 | 717,978 | - | 6.3 | 85,225 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 6.33 per share. | 14 Mar 2023 | 14,164 | 1,091,937 | - | 6.3 | 89,616 | Common Stock |
| Richard A. Cross | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 6.33 per share. | 14 Mar 2023 | 5,516 | 395,170 | - | 6.3 | 34,900 | Common Stock |
| Joseph Konowiecki | Director, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 6.62 per share. | 09 Mar 2023 | 100,000 | 1,018,903 | - | 6.6 | 661,610 | Common Stock |
| David C. Hodgson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 36,337 | 85,716 | - | 0 | Common Stock | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 29,070 | 238,609 | - | 0 | Common Stock | |
| Jeffrey H. Margolis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 21,802 | 74,451 | - | 0 | Common Stock | |
| Jody L. Bilney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 29,070 | 57,744 | - | 0 | Common Stock | |
| Yon Yoon Jorden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 21,802 | 50,476 | - | 0 | Common Stock | |
| Thomas J. Carella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 29,070 | 84,478 | - | 0 | Common Stock | |
| Margaret M. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 21,802 | 83,120 | - | 0 | Common Stock | |
| Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 21,802 | 315,177 | - | 0 | Common Stock | |
| Robbert Vorhoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 36,337 | 85,716 | - | 0 | Common Stock | |
| Dawn Maroney | President, Markets | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Mar 2023 | 6,800 | 1,958,892 | - | 0 | Common Stock | |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 12.19 per share. | 01 Feb 2023 | 10,000 | 1,106,101 | - | 12.2 | 121,921 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.01 per share. | 18 Jan 2023 | 1,100 | 2,723,100 | - | 13.0 | 14,310 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.01 per share. | 18 Jan 2023 | 1,100 | 519,429 | - | 13.0 | 14,308 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 13.01 per share. | 18 Jan 2023 | 1,125 | 1,116,101 | - | 13.0 | 14,633 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 12.54 per share. | 17 Jan 2023 | 5,000 | 1,965,692 | - | 12.5 | 62,721 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 12.09 per share. | 13 Jan 2023 | 9,000 | 1,117,226 | - | 12.1 | 108,818 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 03 Jan 2023 | 1,000 | 1,126,226 | - | 12.0 | 12,013 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 21 Dec 2022 | 4,274 | 1,970,692 | - | 12.0 | 51,345 | Common Stock |
| Dawn Maroney | President, Markets | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2022 | 450 | 1,549,369 | - | 0 | Common Stock | |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 12.02 per share. | 15 Dec 2022 | 726 | 1,974,966 | - | 12.0 | 8,727 | Common Stock |
| Dawn Maroney | President, Markets | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2022 | 5,000 | 1,975,692 | - | 0 | Common Stock | |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.11 per share. | 01 Dec 2022 | 25,000 | 2,724,200 | - | 13.1 | 327,778 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.10 per share. | 01 Dec 2022 | 24,000 | 520,529 | - | 13.1 | 314,446 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 13.08 per share. | 01 Dec 2022 | 20,000 | 1,127,226 | - | 13.1 | 261,572 | Common Stock |
| Joseph Konowiecki | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 53,906 | 918,903 | - | 0 | Common Stock | |
| Joseph Konowiecki | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 35,817 | 35,817 | - | - | Options (Right to Buy) | |
| Margaret M. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 1,429 | 61,318 | - | 0 | Common Stock | |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.23 per share. | 01 Nov 2022 | 25,000 | 2,749,200 | - | 13.2 | 330,830 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.23 per share. | 01 Nov 2022 | 24,000 | 544,529 | - | 13.2 | 317,611 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 13.39 per share. | 01 Nov 2022 | 30,000 | 1,147,226 | - | 13.4 | 401,784 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.07 per share. | 26 Oct 2022 | 25,000 | 2,774,200 | - | 13.1 | 326,855 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.08 per share. | 26 Oct 2022 | 24,000 | 568,529 | - | 13.1 | 313,829 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 13.02 per share. | 26 Oct 2022 | 10,000 | 1,177,226 | - | 13.0 | 130,155 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 12.03 per share. | 03 Oct 2022 | 20,000 | 1,187,226 | - | 12.0 | 240,508 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2022 | 1,639,027 | 2,420,380 | - | 0 | Common Stock | |
| Dawn Maroney | President, Markets | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2022 | 431,323 | 1,981,142 | - | 0 | Common Stock | |
| Robert Thomas Freeman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2022 | 319,179 | 731,448 | - | 0 | Common Stock | |
| Dinesh Kumar | Chief Med & Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2022 | 280,360 | 1,207,226 | - | 0 | Common Stock | |
| Richard A. Cross | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2022 | 102,759 | 400,686 | - | 0 | Common Stock | |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.56 per share. | 01 Sep 2022 | 50,000 | 2,799,200 | - | 14.6 | 727,935 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 14.56 per share. | 01 Sep 2022 | 20,000 | 1,560,069 | - | 14.6 | 291,142 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.56 per share. | 01 Sep 2022 | 24,000 | 592,529 | - | 14.6 | 349,363 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 14.56 per share. | 01 Sep 2022 | 30,000 | 976,866 | - | 14.6 | 436,782 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 23 Aug 2022 | 50,000 | 1,006,866 | - | 16.0 | 800,065 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 15.90 per share. | 22 Aug 2022 | 16,287 | 1,593,782 | - | 15.9 | 259,011 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 15.93 per share. | 22 Aug 2022 | 13,713 | 1,580,069 | - | 15.9 | 218,496 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 16.60 per share. | 15 Aug 2022 | 1,790 | 1,610,069 | - | 16.6 | 29,714 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.95 per share. | 11 Aug 2022 | 500,000 | 2,849,200 | - | 16.0 | 7,976,450 | Common Stock |
| Jeffrey H. Margolis | Director | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 05 Aug 2022 | 1,200 | 425,533 | - | 18 | 21,600 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.01 per share. | 05 Aug 2022 | 4,003 | 3,349,200 | - | 19.0 | 76,110 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.54 per share. | 05 Aug 2022 | 62,188 | 3,353,203 | - | 18.5 | 1,152,779 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.01 per share. | 05 Aug 2022 | 2,913 | 616,529 | - | 19.0 | 55,364 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.51 per share. | 05 Aug 2022 | 40,497 | 619,442 | - | 18.5 | 749,761 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 19.01 per share. | 05 Aug 2022 | 2,531 | 1,056,866 | - | 19.0 | 48,110 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 18.51 per share. | 05 Aug 2022 | 41,573 | 1,059,397 | - | 18.5 | 769,533 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.60 per share. | 01 Aug 2022 | 49,152 | 3,416,239 | - | 14.6 | 717,595 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.74 per share. | 01 Aug 2022 | 848 | 3,415,391 | - | 14.7 | 12,500 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 14.47 per share. | 01 Aug 2022 | 20,000 | 1,611,859 | - | 14.5 | 289,440 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.50 per share. | 01 Aug 2022 | 24,000 | 659,939 | - | 14.5 | 348,019 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 14.49 per share. | 01 Aug 2022 | 30,000 | 1,100,970 | - | 14.5 | 434,646 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.08 per share. | 11 Jul 2022 | 4,107 | 3,465,391 | - | 14.1 | 57,808 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 14.30 per share. | 07 Jul 2022 | 14,775 | 1,631,859 | - | 14.3 | 211,243 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 14.12 per share. | 07 Jul 2022 | 25,225 | 1,646,634 | - | 14.1 | 356,285 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.33 per share. | 06 Jul 2022 | 20,699 | 3,469,498 | - | 14.3 | 296,546 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.29 per share. | 06 Jul 2022 | 7,370 | 3,490,197 | - | 14.3 | 105,350 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.88 per share. | 06 Jul 2022 | 42,072 | 3,497,567 | - | 13.9 | 583,842 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.04 per share. | 06 Jul 2022 | 25,752 | 3,539,639 | - | 13.0 | 335,925 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.48 per share. | 05 Jul 2022 | 20,383 | 683,939 | - | 12.5 | 254,404 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 12.41 per share. | 05 Jul 2022 | 16,317 | 1,150,970 | - | 12.4 | 202,517 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 13.04 per share. | 05 Jul 2022 | 20,000 | 1,130,970 | - | 13.0 | 260,786 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.40 per share. | 01 Jul 2022 | 12,000 | 704,322 | - | 11.4 | 136,838 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 11.40 per share. | 01 Jul 2022 | 10,000 | 1,167,287 | - | 11.4 | 113,980 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 21 Jun 2022 | 100 | 716,322 | - | 12 | 1,200 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 21 Jun 2022 | 3,517 | 716,422 | - | 12.0 | 42,249 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 21 Jun 2022 | 100 | 1,177,287 | - | 12 | 1,200 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 21 Jun 2022 | 3,583 | 1,177,387 | - | 12.0 | 43,035 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.18 per share. | 17 Jun 2022 | 12,000 | 719,939 | - | 11.2 | 134,114 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 10.96 per share. | 16 Jun 2022 | 2,150 | 1,671,859 | - | 11.0 | 23,564 | Common Stock |
| Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 11.04 per share. | 16 Jun 2022 | 10,000 | 1,180,970 | - | 11.0 | 110,393 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 11.10 per share. | 02 Jun 2022 | 13,782 | 1,674,009 | - | 11.1 | 153,017 | Common Stock |
| Dawn Maroney | President, Markets | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Apr 2022 | 15,000 | 1,699,206 | - | 0 | Common Stock | |
| Dawn Maroney | President, Markets | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Apr 2022 | 9,415 | 1,687,791 | - | 0 | Common Stock | |
| Dawn Maroney | President, Markets | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Apr 2022 | 1,000 | 1,697,206 | - | 0 | Common Stock | |
| Dawn Maroney | President, Markets | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Apr 2022 | 1,000 | 1,698,206 | - | 0 | Common Stock | |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.18 per share. | 31 Mar 2022 | 26,366 | 781,353 | - | 11.2 | 294,656 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 11.18 per share. | 31 Mar 2022 | 6,681 | 1,714,206 | - | 11.2 | 74,664 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.18 per share. | 31 Mar 2022 | 4,944 | 415,561 | - | 11.2 | 55,253 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.42 per share. | 31 Mar 2022 | 3,292 | 412,269 | - | 11.4 | 37,582 | Common Stock |
| Donald Furman | Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 11.18 per share. | 31 Mar 2022 | 3,006 | 1,826,538 | - | 11.2 | 33,594 | Common Stock |
| Dinesh Kumar | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.18 per share. | 31 Mar 2022 | 3,058 | 1,190,970 | - | 11.2 | 34,175 | Common Stock |
| Richard A. Cross | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 11.18 per share. | 31 Mar 2022 | 1,592 | 297,927 | - | 11.2 | 17,792 | Common Stock |
| David C. Hodgson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 16,556 | 49,379 | - | 0 | Common Stock | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 16,556 | 209,539 | - | 0 | Common Stock | |
| Jeffrey H. Margolis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 19,316 | 52,649 | - | 0 | Common Stock | |
| John E. Kao | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 496,689 | 807,719 | - | 0 | Common Stock | |
| John E. Kao | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 364,964 | 364,964 | - | - | Options (Right to Buy) | |
| Joseph Konowiecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 33,113 | 864,997 | - | 0 | Common Stock | |
| Thomas J. Carella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 22,075 | 55,408 | - | 0 | Common Stock | |
| Margaret M. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 16,556 | 59,889 | - | 0 | Common Stock | |
| Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 16,556 | 293,375 | - | 0 | Common Stock | |
| Robbert Vorhoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 16,556 | 49,379 | - | 0 | Common Stock | |
| Dawn Maroney | President, Markets | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 152,068 | 152,068 | - | - | Options (Right to Buy) | |
| Dawn Maroney | President, Markets | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 206,954 | 1,720,887 | - | 0 | Common Stock | |
| Robert Thomas Freeman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 100,365 | 100,365 | - | - | Options (Right to Buy) | |
| Robert Thomas Freeman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 136,589 | 420,505 | - | 0 | Common Stock | |
| Dinesh Kumar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 206,954 | 1,194,028 | - | 0 | Common Stock | |
| Dinesh Kumar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 152,068 | 152,068 | - | - | Options (Right to Buy) | |
| Richard A. Cross | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 49,669 | 299,519 | - | 0 | Common Stock | |
| Richard A. Cross | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 36,496 | 36,496 | - | - | Options (Right to Buy) | |
| Jody L. Bilney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 28,674 | 28,674 | - | 0 | Common Stock | |
| Yon Yoon Jorden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 28,674 | 28,674 | - | 0 | Common Stock | |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.11 per share. | 23 Nov 2021 | 419,646 | 3,565,391 | - | 20.1 | 8,438,032 | Common Stock |
| Mark B. McClellan | Director | Sale of securities on an exchange or to another person at price $ 20.11 per share. | 23 Nov 2021 | 7,500 | 276,819 | - | 20.1 | 150,806 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 20.11 per share. | 23 Nov 2021 | 127,843 | 1,513,933 | - | 20.1 | 2,570,603 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.11 per share. | 23 Nov 2021 | 85,279 | 731,939 | - | 20.1 | 1,714,747 | Common Stock |
| Donald Furman | Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 20.11 per share. | 23 Nov 2021 | 100,000 | 1,829,544 | - | 20.1 | 2,010,750 | Common Stock |
| Dinesh Kumar | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.11 per share. | 23 Nov 2021 | 83,367 | 987,074 | - | 20.1 | 1,676,302 | Common Stock |
| Jeffrey H. Margolis | Director | Sale of securities on an exchange or to another person at price $ 19.82 per share. | 01 Nov 2021 | 1,200 | 426,733 | - | 19.8 | 23,784 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.93 per share. | 01 Nov 2021 | 29,302 | 3,985,037 | - | 19.9 | 583,942 | Common Stock |
| John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.91 per share. | 01 Nov 2021 | 70,698 | 4,014,339 | - | 19.9 | 1,407,675 | Common Stock |
| Dinesh Kumar | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.87 per share. | 01 Nov 2021 | 10,000 | 1,070,441 | - | 19.9 | 198,745 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.38 per share. | 20 Oct 2021 | 23,000 | 817,218 | - | 19.4 | 445,763 | Common Stock |
| David C. Hodgson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2021 | 32,823 | 32,823 | - | 0 | Common Stock, par value $0.001 per share ("Common Stock") | |
| Robbert Vorhoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2021 | 32,823 | 32,823 | - | 0 | Common Stock, par value $0.001 per share ("Common Stock") | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 33,333 | 182,983 | - | 0 | Common Stock | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 17,127 | 149,650 | - | 0 | Common Stock, par value $0.001 per share ("Common Stock") | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 18.00 per share. | 25 Mar 2021 | 10,000 | 192,983 | - | 18 | 180,000 | Common Stock |
| Jeffrey H. Margolis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 33,333 | 472,587 | - | 0 | Common Stock, par value $0.001 per share ("Common Stock") | |
| Margaret M. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 33,333 | 33,333 | - | 0 | Common Stock, par value $0.001 per share ("Common Stock") | |
| Margaret M. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 18.00 per share. | 25 Mar 2021 | 10,000 | 43,333 | - | 18 | 180,000 | Common Stock |
| Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 33,333 | 296,422 | - | 0 | Common Stock, par value $0.001 per share ("Common Stock") | |
| Mark B. McClellan | Director | Sale of securities on an exchange or to another person at price $ 16.83 per share. | 25 Mar 2021 | 12,103 | 284,319 | - | 16.8 | 203,693 | Common Stock |
| Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 16.83 per share. | 25 Mar 2021 | 75,222 | 1,641,776 | - | 16.8 | 1,265,986 | Common Stock |
| Dawn Maroney | President, Markets | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 81,850 | 1,716,998 | - | 0 | Common Stock, par value $0.001 per share ("Common Stock") | |
| Dawn Maroney | President, Markets | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 1,030,702 | 346,296 | - | - | Stock Option (right to buy) | |
| Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.83 per share. | 25 Mar 2021 | 38,919 | 840,218 | - | 16.8 | 655,007 | Common Stock |
| Robert Thomas Freeman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 762,270 | 762,720 | - | - | Stock Option (right to buy) | |
| Robert Thomas Freeman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 60,569 | 283,916 | - | 0 | Common Stock | |
| Robert Thomas Freeman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 57,090 | 223,347 | - | 0 | Common Stock, par value $0.001 per share ("Common Stock") | |
| Michael Curtis Foster | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 27,500 | 1,132,692 | - | 0 | Common Stock, par value $0.001 per share ("Common Stock") | |
| Michael Curtis Foster | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 346,296 | 346,296 | - | - | Stock Option (right to buy) | |
| Michael Curtis Foster | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 16.83 per share. | 25 Mar 2021 | 50,843 | 1,081,849 | - | 16.8 | 855,688 | Common Stock |